HIV vector with EF-1a (EF-1alpha) promoter driving the expression of the CRISPR* spCas9 nuclease. Blasticidin-selectable marker and VSVG envelope. P2A self-cleaving peptide. *Additional royalty fees apply to this technology. MTA required with Salk Institute for first time external customers. Please contact us at email@example.com for information on initiating the agreement.
*These listed prices are per aliquot for non-profit customers only, additional fees may apply.